Real‐World Use of Rituximab in the Treatment of Cold Agglutinin Disease in the United States: A Retrospective Study
<b>Trial Registration</b>: The authors have confirmed clinical trial registration is not needed for this submission.
Authors
- Caroline Piatek (ORCID: https://orcid.org/0000-0001-8628-8348)
- Morie A. Gertz (ORCID: https://orcid.org/0000-0002-3853-5196)
- Gandarvaka Miles
- Brad Ward
- Reena Patel (ORCID: https://orcid.org/0000-0001-6134-3048)
- Ronnie Yoo (ORCID: https://orcid.org/0009-0009-8826-6404)
- Irina Murakhovskaya (ORCID: https://orcid.org/0000-0001-6136-6573)
- Carrie Heller
- Sylvie Bozzi
- Alia Karaouni
- Jacqueline Lucia
Institutions
- Albert Einstein College of Medicine (US)
- Mayo Clinic (US)
- Montefiore Medical Center (US)
- Sanofi (France) (FR)
- Aetion (United States) (US)
- Sanofi (United States) (US)
- USC Norris Comprehensive Cancer Center (US)
- Mayo Clinic in Arizona (US)
- Sarmap (Switzerland) (CH)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- eJHaem
- Published
- 2025-07-12
- DOI
- https://doi.org/10.1002/jha2.70082
- Primary Topic
- Blood groups and transfusion
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi